Details of the Drug Reposition

General Information of This Drug (ID: DMNZ7F2)

Drug Name
CD19.CAR-T cells   DMNZ7F2
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 1/2 [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1/2 [1]
Mantle cell lymphoma DISFREOV 2A85.5 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02652910) Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma